Jim Badke is a leader of Sidley’s IP Litigation practice and heads the New York Intellectual Property group. He is also a leader of the Life Sciences practice. Jim is an established lead trial counsel with numerous recent jury and bench trial victories in bet-the-company cases in courtrooms across the country. Jim recently lead a team in a jury trial in Delaware representing Bayer as a plaintiff against Baxalta on a recombinant Factor VIII patent and secured a complete victory on liability and a $155 million damages award. Jim’s patent trial and litigation practice includes all technologies, focused primarily in the medical device, biotechnology and pharmaceutical industries, including litigation under the Hatch-Waxman Act. His cases in the pharmaceutical industry have included a number of life-saving drugs. Jim also is a pioneer in medical device patent litigation, having continuously litigated cases involving medical device patents for more than 30 years. His cases have involved a wide range of medical device technology. In addition to his trial work, Jim appears regularly before the Court of Appeals for the Federal Circuit, having argued numerous cases before the court, including the landmark Therasense inequitable conduct case, in which the Court sat en banc.